Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Fetal Tissue, Stem Cells & Bioethics

137 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
137 results
featured-image
Fetal Tissue, Stem Cells & Bioethics

Análisis del Instituto Charlotte Lozier (CLI): La mayoría de las vacunas de la Operation Warp Speed no se producen usando células derivadas de abortos

El análisis de CLI encontró que la mayoría de las candidatas a vacunas no utilizaban líneas celulares derivadas de abortos en su producción.  Varios utilizaron líneas celulares derivadas del aborto en pruebas de laboratorio, o bien su uso no pudo determinarse en las pruebas.

charlotte-lozier-institute Charlotte Lozier Institute
December 3, 2020
Please login to bookmark Close
Fetal Tissue, Stem Cells & Bioethics

CLI Analysis: Majority of Operation Warp Speed Vaccines Not Produced Using Abortion-Derived Cells

“CLI’s expert scientific analysis finds that many leading vaccine candidates supported by Operation Warp Speed do not use abortion-derived cell lines in their production. This is encouraging news.

featured-image
Fetal Tissue, Stem Cells & Bioethics

COVID-19, Nursing Homes, and the Need to Protect the Elderly

In early 2020 news began circulating that a life-threatening respiratory illness was sweeping across the world and had made its way to the United States. Reactions to the severity of the problem varied, but most jurisdictions seemed underprepared to deal with how COVID-19 would impact long-term care facilities, specifically nursing homes.

featured-image
Fetal Tissue, Stem Cells & Bioethics

CLI Responds to Misinformation Regarding President Trump’s COVID-19 Treatment

“Uninformed commentary has emerged this morning stating that President Trump has received a medication created with the use of human embryonic stem cells.  CLI has reviewed the published information and our conclusion is straightforward: The president was not given any medicines to treat COVID-19 that involved the destruction of human life.  No human embryonic stem cells or human fetal tissue were used to produce the treatments President Trump received--period.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Federal Bioethics Commissions and Bias Against the Unborn

In August, the Trump administration’s new Human Fetal Tissue Research Ethics Advisory Board reviewed requests made to the National Institutes of Health (NIH) for federally funded fetal tissue research. The Board recommended denying most of these requests.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines

Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine.  One concern regarding the ethical assessment of viral vaccine candidates is the potential use of abortion-derived cell lines in the development, production or testing of a vaccine.  This analysis utilizes data from the primary scientific literature when available, along with data from clinical trial documents, reputable vaccine tracking websites, and published commercial information.1  It is the hope that by providing accurate data, recipients can make well-informed decisions regarding vaccine choices.

featured-image
Fetal Tissue, Stem Cells & Bioethics

A Policy and Funding Evaluation Of Human Fetal Tissue Research

Here we evaluate the actions and policy changes made by the Trump administration that have been taken since his term in office and analyze the current standing of federal funds used to support fetal tissue research.  First, we give a brief overview of how federal tax dollars are used to fund medical research in the U.S.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Designing Babies: Science, Ethics, and Policies of a Post-Genomic Era

At the Center for Bioethics and Human Dignity annual summer conference "Bioethics in Real Life,” Dr. David Prentice and Dr. Tara Sander Lee presented a workshop entitled Designing Babies: Science, Ethics, and Policies of a Post-Genomic Era. Scientific advancements in the fields of genetics, molecular diagnosis, and genetic engineering were introduced so that participants could better understand the benefits, risks, limitations, policies, and potential impact on society. The ethics were carefully evaluated and discussed.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image